Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Rf most likely forward sell shares as they have done recently. However they may ease release rate to capitalise on gain. Warrants they have 4 years and early tranche was for them to buy at 147p.
Shares will become scarce soon and we are leading up to news time.
Riverfort having a few options is no problem, A company choosing to on license pr partnership will not touch us with a barge pole.
At the moment just be patient for the SP to rerate itself in the 70 to 75 million market cap.
A few weeks is all!
Regards
Nicely you have no confidence on this share at all. You write rubbish too.
You average for SAR was 4 pound 70.
How on earth you manage that?
Caught on a spike?
100k down on this share?
100k down on another share too you claim?
You are a MAJW&CO disciple me thinks.
Regards
Not volume as such. You cannot use the drawdown facility at more than 1 million debt balance. The amount owing with drawdown cannot be greater than 10% of market cap.
Manipulated to create financial chaos.
I should think they looked at the detail in the small print am sure even Stevie Wonder could have found it.
Regards
Not volume as such. You cannot use the drawdown facility at more than 1 million debt balance. The amount owing with drawdown cannot be greater than 10% of market cap.
Manipulated to create financial chaos.
I should think they looked at the detail in the small print am sure even Stevie Wonder could have found it.
Regards
Good morning nicely,
Have you by any chance taken notice of the trading volumes. This will not be going back to 10.5p per share.
People will take profits on the way up that is the way the cookie crumbles, it will reach a pound plus over time.
You can have a positive attitude here ut there are some who will insult, undermine and create disruption and so much fear.
One little berk was even calling for me to get banned as l was the cause of people losing money here.
Well, l don't hear them now, do you not find that strange?
I know it would be boring in life if we were all the same, but we are not. We are individuals, but the ultimate objective here is to make a reasonable sum of money.
I have been here since 2012 and other LTH's a tad longer.
This company has been put through the mill since
2022. Now it is on the up and much further forward. 34p a share is still a pittance for where we stand.
However, the new investor or trader needs exercise a degree of caution. There is plenty of info about.
Regards
Good evening fearg,
Similar opinions as myself, definate downward pressure by RF to to put financial destruction on Sareum. From the RNS of today the rerate has begun.
RF can sell what they like. Hence gradual grind over 6 months,from Aug to Feb (105p to 60p ) and then from Feb to March dropped 60p to 10p.
Another raise and shares may have been manipulated down to less than a penny. RF come along kindly help with more peanut finance and acquire Sareum. Sold in the hundreds of millions later!
Share price was 105p prior to RF involvement.
Circa 70 million shares at that time, now around 105 so approx 50% dilution.
So realistically we are looking at 70p per share to bring the SP or to be more precise the Market Cap of 70 million.
Now 1801 has advanced since, as we now await safety data results that we expect to enable us to traverse into a company that has a phase 2 asset.
In addition we await news of the licensee that has taken on 737 a checkpoint 1 kinase inhibitor.
Checkpoint kinase inhibitors are effective at what they are designed to do, but to satisfy the demands of regulating authorities such as the NDA they need to be used in combination therapy satisfactorily to gain clinical use authorisations.
With regards to 1801 that will also have a knock on effect to 1802.
I would suggest that on satisfactory 1801 news we can expect a minimum 50% to 100% rise. On commencement of phase 2a trial (that may require raising of funds to bring the Mcap to around 150 to 175 million.
News on 737 maybe 5 to 7.5 million as a rough guide.
155 to 180 million market cap
Approx 150p to 180p per share.
On licence will depend on phase 2 data.
End of phase 2 as l have put before an upfront payment of between 200 and 400 million and with good Indications outside of psoriasis maybe up to 800 million.
No Jaki inhibitors irrelevant of selectivity have ever been authorised for clinical use without the dreaded black box warnings.
Allosteric TYK2 Deucravacitinib)has proven so far excellent with regards to safety albeit the efficacy on Psoriasis is adequate, it is believed by using the dual inhibition approach of Tyk2 and Jak1 that this would yield superior efficacy over Tyk2 alone. 1801 is Tyk 2 Jak1 an oral formulation that has the added underestimated benefit of being administered in a capsule formulation.
The safety profile of SDC-1801 if comparable to Deucravacitinib would make us available for clinical use without the dreaded black box warnings and a greater efficacy in certain Indications.
Let's face it Deucravacitinib flunked badly in UC.
This all new allosteric Tyk2 inhibitor that regulates the active domain via the pseudo domain?
How much would 1801 be worth with a safety profile comparable with Deucracitinib but better efficacy?
Mind blowing!
Regards
I should not think anyone else wanting to take a drawdown against Riverfort finance.
They are now gone.
We will be finding out who recommended them, even if it means waiting to the AGM.
Those that have bailed the company out should receive options. The BoD need nailing for this catastrophe, and l hope they read this chat board.
Rant over, onwards and upwards and should not be long before we receive an update on 737 or 1801.
Regards
Well spotted Prince mincer,
In the 20's stll, as news not only of a further drawdown of 3,000,000 shares but the vast number of these forward sold into the market today.
How many of your 1,700 shares do you have left?
Did you take advantage of the WRAP offer?
Have you added or sold any?
Clearly, you are very easily disappointed. I take you have no disappointment with RF?
New week starts Monday, RF doing their utmost to destroy the SP but will be gone very soon.
220k still to pay around 2.2 million shares.
Price will climb steadily with Riverfort out of the equation.
I am not disappointed as bought another 10k.
Good evening Gregorio.
Of what interest do we have here of how old you are and where you live.? You have friends too.
How quaint.
It could have been worse l suppose.
I am an 83 year old happy man with friends living in Spain, distance no object.
Go ahead and short Sar and tell us about that,it would be more interesting and relevant.
You have missed the boat if you believe shorting is a good idea.
A good day all on all RF will not have many more shares left and around Thursday next week at the latest they will recieve discounted shares to the value of 220k.
Bye bye Riverfort.
Then we await news on SDC1801 basically to state we are in a position to progress to phase 2a trials.
With Riverfort clawhammer coated out of the door, it will open up on licensing, and partnership avenues and you cannot rule out a buyout offer within next 12 months.
RNS stating 3,000,000 shares issued.
Most of these already gold l would suggest.
No more 3 million shares to be issued after this current issue.
Very predictable RNS,
Nicely, seemed very concerned for us all about the impending issuance of new shares.
According to one of his posts, he needs 5 pounds to break even, poor sod.
That MAJWandCo thankyou for posting. Have tripled my holding here and took advantage of the WRAP offer.
You knew and know nothing of the science here as you have demonstrated.
Is it just coincidence that MAJW the first and last letters of the CLO a Mr Mark Wheeler are the same.
You get to see him on the golf course along with James Rooke? They both love golf with even the Riverfort CLO commentating on the reduction of his golf handicap.
Maybe you were on the golf course this morning,
All done very nicely.
Regards